Health
Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower). WILMINGTON, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clove
About this update from Clover Health Investments, Corp.
[{"type":"image","alt":"Clover Health Investments, Corp.","displaySize":"","headline":null,"caption":"Clover Health Investments, Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":69,"url":"https://media.zenfs.com/en/globenewswire.com/5220c2eec2b7aec2d58005b5a05e9207"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1HrSYo.eR7ZNai2k9C6CsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/5220c2eec2b7aec2d58005b5a05e9207","width":300,"height":69}},"lazy":false},{"type":"text","content":"New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower).","length":321,"tagName":"p"},{"type":"text","content":"WILMINGTON, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a new whitepaper demonstrating how Counterpart Assistant (“CA”) technology supports improved management of COPD. The analysis, titled “Driving Clinical Excellence in Chronic Disease: Counterpart Assistant’s Role in Chronic Obstructive Pulmonary Disease Care,” details strong correlations between CA-enabled primary care and better identification, management, and outcomes for COPD patients enrolled in Clover Health’s Medicare Advantage (MA) plans.","length":735,"tagName":"p"},{"type":"text","content":"Key highlights of the study include:","length":36,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Greater disease identification: New members with no prior COPD diagnosis who joined a Clover MA plan from another MA plan were 75% more likely to be diagnosed with COPD within their first year of joining Clover when under the care of a PCP that uses CA.","length":253,"tagName":"p"}]},{"val":[{"type":"text","content":"More frequent specialty care access: COPD patients attributed to a PCP that uses CA recorded an 18% higher average number of outpatient pulmonology visits.","length":155,"tagName":"p"}]},{"val":[{"type":"te...